ComKardia
Newton, US · Founded 2021 · Delaware corporation
ComKardia is developing an AI-powered decision-support platform for coronary artery disease and PCI planning that builds a patient-specific digital twin to help interventional cardiologists plan stent selection, sizing, and placement within the cath lab workflow. The company targets interventional cardiology and plans to distribute its imaging-guided PCI software through a licensing and SaaS model.
Founders & leadership
IC
Ioannis ChatzizisisNamed on SEC filing
MK
Maria KyparissopoulouNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2022
▶$250KraisedSep 2022 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedSep 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ioannis ChatzizisisDirector
- Maria KyparissopoulouExecutive Officer, Director
- Offering amount
- $3.1M
- Amount sold
- $250K
- Proceeds to insiders
- $21K
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 7
by search overlap
AliveCor7 shared keywordsAliveCor develops digital health solutions focused on cardiovascular care, serving employers and healthcare payers seeking enterprise heart health platforms.
Zendesk5 shared keywordsThis is Zendesk's internal belonging/diversity and inclusion program page, not a company profile page for an external company. It describes Zendesk's internal culture initiatives and leadership development programs.
SymKardia4 shared keywordsSymKardia develops a selective cardiac neuromodulation therapy to treat cardiac arrhythmias such as atrial fibrillation, targeting the nervous system rather than only cardiac tissue. It is a clinical-stage cardiovascular medical device company running pre-clinical and clinical research programs.
AccurKardia4 shared keywordsAccurKardia develops AI-based technology for cardiac monitoring and ECG interpretation, serving clinicians and healthcare providers. It operates in the cardiology-focused medtech and digital health space.
Instacart4 shared keywordsInstacart operates a marketplace connecting grocery retailers with customers who order food and household items for same-day delivery or in-store pickup, serving millions of households across North America through partnerships with over 350 retailers.
Seamless3 shared keywordsSeamless.AI is a real-time search engine and sales intelligence platform that finds and verifies B2B prospect contact data, automates outreach, and books meetings. It serves revenue teams including sales leaders, SDRs, account executives, RevOps, and marketing.
Carda3 shared keywordsCarda Health provides at-home virtual cardiac and pulmonary rehabilitation for patients with conditions like COPD and heart disease, delivering physician-supervised care through clinical exercise physiologists with live vital-sign monitoring. The company ships patients a care kit and matches them with clinicians for personalized, remotely-supervised exercise, nutrition, and stress-management programs.
Companies competing with ComKardia for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does ComKardia do?
- ComKardia is developing an AI-powered decision-support platform for coronary artery disease and PCI planning that builds a patient-specific digital twin to help interventional cardiologists plan stent selection, sizing, and placement within the cath lab workflow. The company targets interventional cardiology and plans to distribute its imaging-guided PCI software through a licensing and SaaS model.
- How much funding has ComKardia raised?
- ComKardia has disclosed $250K raised across 1 round.
- Where is ComKardia headquartered?
- ComKardia is headquartered in Newton, US.